MARTINA ZILIC: Open Payments
NPI 1730871161 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 13 payments from 7 companies in 2025. Trend: 2023 $179 · 2024 $358 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $171 |
| BTG International Inc. | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Adaptive Biotechnologies Corporation | 1 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $27 |
| Celgene Corporation | 1 | $22 |
| Legend Biotech USA Inc. | 1 | $21 |
Products named: VORAXAZE, TECVAYLI, CARVYKTI, NINLARO, clonoSEQ, TALVEY, XPOVIO, ABECMA.
Industry payments across WA — which companies pay providers there.
